Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53 ; volume:44 ; number:1 ; year:2017 ; pages:255-266
Cellular physiology and biochemistry ; 44, Heft 1 (2017), 255-266
- Urheber
-
Liu, Jinjin
Rao, Jun
Lou, Xuming
Zhai, Jian
Ni, ZhenHua
Wang, Xiongbiao
- DOI
-
10.1159/000484678
- URN
-
urn:nbn:de:101:1-2018012419453
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Jinjin
- Rao, Jun
- Lou, Xuming
- Zhai, Jian
- Ni, ZhenHua
- Wang, Xiongbiao
Ähnliche Objekte (12)
NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity
SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma
miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
The oncogenic role of TRIP13 in hepatocellular carcinoma
The Oncogenic Role of Trip13 in Hepatocellular Carcinoma
Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
Long non-coding RNA LINC01559 exerts oncogenic role via enhancing autophagy in lung adenocarcinoma
Constitutive Photomorphogensis Protein1 (COP1) mediated p53 pathway and its oncogenic role
Oncogenic p53 triggers amyloid aggregation of p63 and p73 liquid droplets
NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity
SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma
miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
The oncogenic role of TRIP13 in hepatocellular carcinoma
The Oncogenic Role of Trip13 in Hepatocellular Carcinoma
Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
Long non-coding RNA LINC01559 exerts oncogenic role via enhancing autophagy in lung adenocarcinoma
Constitutive Photomorphogensis Protein1 (COP1) mediated p53 pathway and its oncogenic role
Oncogenic p53 triggers amyloid aggregation of p63 and p73 liquid droplets
NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity
SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma
miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
The oncogenic role of TRIP13 in hepatocellular carcinoma
The Oncogenic Role of Trip13 in Hepatocellular Carcinoma
Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
Long non-coding RNA LINC01559 exerts oncogenic role via enhancing autophagy in lung adenocarcinoma
Constitutive Photomorphogensis Protein1 (COP1) mediated p53 pathway and its oncogenic role